Adaptive Immunity Buildup against Malaria in Comparison to Sars-Cov-2 Fair Resistance in Sub-Saharan Africa

Abstract

Currently, the existence of mankind is under a serious threat posed by the spread of novel SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) also referred to as COVID-2019 [Coronavirus disease 2019] or 2019-nCoV [2019 novel coronavirus].The number of cases across the globe is still on the increase and there has been an urgent need for therapeutic alternatives to alleviate and fight down this pandemic. It is worthy of note that Africa, with high poverty index is still at the base of the countries ravaged by SARS-CoV-2 and this is not far-fetched. Many Africans over the years have been exposed severally to Mosquito bites and malaria infections against which their bodies having been subjected to several doses of different anti-malaria drugs both clinical and traditional (for those who could not afford the cost of clinical drugs) therefore demonstrate strong immunity against SARS-CoV-2; a virus which responds positively to some of the anti-malaria drugs with anti-viral effects such as Chloroquine and Artemisin in widely distributed across Africa. This mini-review aims at providing a quick idea as to the adaptive immunity buildup against malaria by some Africans (mostly in the sub-Saharan region) in comparison to SARS-CoV-2 fair resistance vis-í -vis the effectiveness of supplementing clinical drugs with traditional herbsas a potential solution to this pandemic outbreak.